Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra Lifesciences (NQ: IART )

31.53 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 31.53
Bid (Size) 27.50 (2)
Ask (Size) 50.44 (2)
Prev. Close 31.53
Today's Range 31.53 - 31.53
52wk Range 22.36 - 46.75
Shares Outstanding 84,579,542
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
8 Analysts Have This To Say About Integra Lifesciences
Via Benzinga

Performance

YTD
-27.10%
-27.10%
1 Month
+5.70%
+5.70%
3 Month
+8.80%
+8.80%
6 Month
-26.86%
-26.86%
1 Year
-30.99%
-30.99%

More News

Read More
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
Via Chartmill
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
From Kahn Swick & Foti, LLC
Via Business Wire
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
Via Chartmill
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Via Benzinga
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
Via Benzinga
Recap: Integra Lifesciences Q4 Earnings
Via Benzinga
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
The Analyst Landscape: 7 Takes On Integra Lifesciences
Via Benzinga
The Latest Analyst Ratings for Integra Lifesciences
Via Benzinga
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
Via Benzinga
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
Via Benzinga
IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024
Via InvestorPlace
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
From Pomerantz LLP
Via GlobeNewswire
NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
Via Chartmill
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
Via Benzinga
NASDAQ:IART, an undervalued stock with good fundamentals.
Via Chartmill
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.